COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 84 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2017. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,815,000 | -13.1% | 138,029 | 0.0% | 0.11% | -18.5% |
| Q1 2019 | $2,089,000 | -28.8% | 138,029 | -19.2% | 0.13% | -42.2% |
| Q4 2018 | $2,934,000 | -41.0% | 170,929 | -49.3% | 0.22% | -17.9% |
| Q3 2018 | $4,973,000 | -59.0% | 337,429 | -33.7% | 0.27% | -60.2% |
| Q2 2018 | $12,135,000 | +56.6% | 508,822 | +67.8% | 0.69% | +72.7% |
| Q1 2018 | $7,748,000 | -27.5% | 303,222 | -47.7% | 0.40% | -18.7% |
| Q4 2017 | $10,693,000 | +17.6% | 579,234 | -33.2% | 0.49% | +22.4% |
| Q3 2017 | $9,092,000 | -18.7% | 866,747 | -3.0% | 0.40% | -15.8% |
| Q2 2017 | $11,180,000 | +4.3% | 893,688 | -16.1% | 0.48% | -12.7% |
| Q1 2017 | $10,714,000 | +0.5% | 1,065,000 | +55.5% | 0.54% | +8.8% |
| Q4 2016 | $10,664,000 | +69.6% | 684,909 | +109.8% | 0.50% | +160.9% |
| Q3 2016 | $6,289,000 | +228.2% | 326,500 | +102.0% | 0.19% | +143.0% |
| Q2 2016 | $1,916,000 | -58.8% | 161,625 | -36.9% | 0.08% | -61.5% |
| Q1 2016 | $4,649,000 | – | 256,125 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |